Nordea Investment Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.97M | Buy |
|
|||||
|
2025
Q2 | $2.21M | Buy |
|
|||||
|
2025
Q1 | $1.37M | Sell |
|
|||||
|
2024
Q4 | $1.66M | Buy |
|
|||||
|
2024
Q3 | $2.03M | Sell |
|
|||||
|
2024
Q2 | $1.55M | Sell |
|
|||||
|
2024
Q1 | $2.11M | Sell |
|
|||||
|
2023
Q4 | $2.17M | Sell |
|
|||||
|
2023
Q3 | $1.67M | Buy |
|
|||||
|
2023
Q2 | $2.19M | Buy |
|
|||||
|
2023
Q1 | $734K | Sell |
|
|||||
|
2022
Q4 | $894K | Buy |
|
|||||
|
2022
Q3 | $810K | Sell |
|
|||||
|
2022
Q2 | $1.2M | Buy |
|
|||||
|
2022
Q1 | $660K | Buy |
|
|||||
|
2021
Q4 | $656K | Hold |
|
|||||
|
2021
Q3 | $674K | Hold |
|
|||||
|
2021
Q2 | $733K | Buy |
|
|||||
|
2021
Q1 | $800K | Buy |
|